比较新鲜与冷冻母乳喂养早产儿的随机对照试验方案
本研究为多中心、双盲、随机对照试验方案,纳入中国29家三级NICU收治的<30周早产儿,干预组每日至少2次新鲜母乳(挤出后4小时内),对照组按标准使用冷冻母乳。主要结局为32周矫正年龄时死亡或≥2期NEC的复合结局,旨在评估新鲜母乳能否改善早产儿结局。
要点
- 新鲜母乳每日至少2次喂养或可降低早产儿死亡或≥2期NEC风险。
- 研究纳入<30周早产儿,干预从入组至32周矫正年龄或出院。
- 主要结局为死亡或≥2期NEC的复合结局。
核心结论
- 该随机对照试验旨在检验新鲜母乳能否改善早产儿结局,结果将影响中国及国际早产儿喂养实践与政策。
研究设计与样本
- 多中心、双盲、随机对照试验方案,纳入中国29家三级NICU收治的<30周早产儿。
- 干预组1549例每日至少2次新鲜母乳(挤出后4小时内),对照组1549例按标准使用冷冻母乳。
关键数值与推荐
- 主要结局为32周矫正年龄时死亡或≥2期NEC的复合结局。
- 次要结局包括死亡、≥2期NEC、需手术NEC、晚发性脓毒症、ROP、BPD、体重增长、体重变化、身长增长、头围增长、达到全肠内喂养时间及临界事件报告数量和类型。
临床怎么用
- 若结果支持新鲜母乳优势,可推动NICU鼓励母亲进入病房挤取新鲜母乳喂养早产儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Necrotizing enterocolitis (NEC) is the leading cause of death among preterm infants born at < 30 weeks' gestation. The incidence of NEC is reduced when infants are fed human milk. However, in many neonatal intensive care units (NICUs), it is standard practice to freeze and/or pasteurize human milk, which deactivates bioactive components that may offer additional protective benefits. Indeed, our pilot study showed that one feed of fresh mother's own milk per day was safe, feasible, and can reduce morbidity in preterm infants. To further evaluate the benefits of fresh human milk in the NICU, a randomized controlled trial is needed. METHODS: Our prospective multicenter, double-blinded, randomized, controlled trial will include infants born at < 30 weeks' gestation and admitted to one of 29 tertiary NICUs in China. Infants in the intervention (fresh human milk) group (n = 1549) will receive at least two feeds of fresh human milk (i.e., within 4 h of expression) per day from the time of enrollment until 32 weeks' corrected age or discharge to home. Infants in the control group (n = 1549) will receive previously frozen human milk following the current standard protocols. Following informed consent, enrolled infants will be randomly allocated to the control or fresh human milk groups. The primary outcome is the composite outcome mortality or NEC ≥ stage 2 at 32 weeks' corrected age, and the secondary outcomes are mortality, NEC ≥ stage 2, NEC needing surgery, late-onset sepsis, retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD), weight gain, change in weight, increase in length, increase in head circumference, time to full enteral feeds, and finally, the number and type of critical incident reports, including feeding errors. DISCUSSION: Our double-blinded, randomized, controlled trial aims to examine whether fresh human milk can improve infant outcomes. The results of this study will impact both Chinese and international medical practice and feeding policy for preterm infants. In addition, data from our study will inform changes in health policy in NICUs across China, such that mothers are encouraged to enter the NICU and express fresh milk for their infants. TRIAL REGISTRATION: Chinese Clinical Trial Registry; #ChiCTR1900020577; registered January 1, 2019; http://www.chictr.org.cn/showprojen.aspx?proj=34276.
引用
- Sun H, Cao Y, Han S, et al. A randomized controlled trial protocol comparing the feeds of fresh versus frozen mother's own milk for preterm infants in the NICU. Trials. 2020. PMID: 32046760. doi:10.1186/s13063-019-3981-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。